Construction of a DNA Nanoassembly Based on Spatially Ordered Recognition Elements for Inhibiting ß-Amyloid Aggregation.
Langmuir
; 39(6): 2192-2203, 2023 02 14.
Article
en En
| MEDLINE
| ID: mdl-36735839
ABSTRACT
A ß-amyloid (Aß) aggregation process is a spontaneous process where the original random coil or helical structure changes into a regularly arranged ß-sheet structure. The development of inhibitors with the features of low cost, high efficiency, and biosafety by targeting Aß self-aggregation is significant for Alzheimer's disease treatment. However, the issues of low inhibition efficiency under low concentrations of inhibitors and biological toxicity are currently to be addressed. To resolve the above problems, a DNA nanoassembly (HCR-Apt) based on spatially ordered recognition elements was constructed by targeted disruption of Aß ordered arrangement. It was discovered that HCR-Apt could inhibit effectively the fibrillation of Aß40 monomers and oligomers at substoichiometric ratios. This may be due to orderly arrangement of aptamers in rigid nanoskeletons for enhancing the recognition interaction between aptamers and Aß40. The strong interaction between HCR-Apt and Aß40 limited the flexible conformational conversion of Aß40 molecules, thereby inhibiting their self-assembly. Computational simulations and experimental analysis revealed the interactions of Apt42 with Aß40, which explained different inhibition effects on the fibrillation of Aß40 monomers and oligomers. Furthermore, the analysis of tyrosine intrinsic fluorescence spectra and surface plasmon resonance imaging showed that the interaction of HCR-Apt and Aß40 was stronger than that of Apt42 and Aß40. These findings contributed to establishing a promising method of boosting the recognition interaction by orderly arrangement of recognition elements. Taken together, this work is expected to provide a simple and efficient strategy for inhibiting Aß aggregation, expanding aptamer's application potential in neurodegenerative diseases.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Péptidos beta-Amiloides
/
Enfermedad de Alzheimer
Límite:
Humans
Idioma:
En
Revista:
Langmuir
Asunto de la revista:
QUIMICA
Año:
2023
Tipo del documento:
Article